CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival
Leukemia
.
2024 Nov 22.
doi: 10.1038/s41375-024-02463-9.
Online ahead of print.
Authors
Gerardo Ferrer
1
2
3
,
Florencia Palacios
4
5
,
Pui Yan Chiu
6
,
Kelly Wong
4
,
Alberto Bueno-Costa
7
8
,
Jacqueline C Barrientos
4
9
10
,
Jonathan E Kolitz
4
9
10
,
Steven L Allen
4
9
10
,
Kanti R Rai
4
9
10
,
Shih-Shih Chen
4
,
Barbara Sherry
6
10
11
,
Nicholas Chiorazzi
4
9
10
11
Affiliations
1
Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.
[email protected]
.
2
Cancer Epigenetics, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
[email protected]
.
3
Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Madrid, Spain.
[email protected]
.
4
Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.
5
Chronic Lymphocytic Leukemia laboratory Research, Institut Pasteur Montevideo, Montevideo, Uruguay.
6
Center for Immunology & Inflammation, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.
7
Cancer Epigenetics, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
8
Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Madrid, Madrid, Spain.
9
Department of Medicine, Northwell Health, Manhasset and New Hyde Park, Manhasset, NY, USA.
10
Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, 11549, USA.
11
Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, 11549, USA.
PMID:
39578533
DOI:
10.1038/s41375-024-02463-9
No abstract available
Grants and funding
R01CA238523/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
R01CA238523/U.S. Department of Health & Human Services | National Institutes of Health (NIH)